Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07348718 · ClinicalTrials.gov registry record

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

A clinical trial of Diabetic Kidney Disease (DKD), sponsored by Rubix LS.

Active
Registry status
2,000
Enrollment target
1
Study location

NCT07348718 is a study of Diabetic Kidney Disease (DKD) that is active but no longer recruiting, run by Rubix LS. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07348718, a study of Diabetic Kidney Disease (DKD), is active but no longer recruiting, sponsored by Rubix LS.

ACTIVE NOT RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

Diabetic kidney disease (DKD) is a common complication of type 2 diabetes that can lead to kidney failure and increases the risk of cardiovascular disease. This prospective, observational patient registry will follow adults with type 2 diabetes and DKD who are receiving routine clinical care at participating sites, with intentional enrollment from underserved communities. Health information will be collected from medical records and brief questionnaires (including social and access factors) for up to 24 months to understand DKD progression, real-world treatment patterns, and outcomes. This study does not assign any treatment. With participant consent and appropriate privacy safeguards, de-identified registry data may be shared with researchers to accelerate evidence generation and inform future studies focused on improving outcomes.

Interventions

  • DRUG Kidney-Protective Therapies Used in Routine Care

Study Locations (1)

Massachusetts

  • Rubix LS - Lawrence

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-12-15
Est. Completion 2026-04-01

Sponsor

Rubix LS

2 total trials

What the Registry Record Tells You About NCT07348718

The ClinicalTrials.gov registry entry for NCT07348718 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rubix LS, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Kidney Disease (DKD) appearing as the primary indexed condition, and to 1 intervention - of which Kidney-Protective Therapies Used in Routine Care is the first listed.

NCT07348718 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07348718 about?

NCT07348718 is a clinical study titled "Rubix LS Diabetic Kidney Disease (DKD) Registry Study". Diabetic kidney disease (DKD) is a common complication of type 2 diabetes that can lead to kidney failure and increases the risk of cardiovascular disease. This prospective, observational patient registry will follow adults with type 2 diabetes and DKD who are receiving routine clinical care at part...

What is the current status of trial NCT07348718?

This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2025-12-15. Estimated completion is 2026-04-01.

What conditions does trial NCT07348718 study?

This clinical trial studies the following conditions: Diabetic Kidney Disease (DKD).

What interventions are being tested in trial NCT07348718?

The interventions under investigation include: Kidney-Protective Therapies Used in Routine Care (DRUG).

Who is sponsoring clinical trial NCT07348718?

This trial is sponsored by Rubix LS, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07348718 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Kidney Disease (DKD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.